Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

Trial Profile

Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

Completed
Phase of Trial: Phase I/II

Latest Information Update: 07 Sep 2016

At a glance

  • Drugs T-cell vaccine-TVAX Biomedical (Primary) ; Interleukin-2
  • Indications Glioma
  • Focus Therapeutic Use
  • Sponsors TVAX Biomedical
  • Most Recent Events

    • 25 Jun 2014 New trial record
    • 26 Aug 2010 According to CT.gov record, status changed from recruiting to active, no longer recruiting.
    • 12 Apr 2010 According to CT.gov record, status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top